Anaplastic Oligodendroglioma (AO) Completed Phase 1 Trials for Irinotecan (DB00762)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00734682A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade GliomasTreatment